American Society of Gene & Cell Therapy (ASGCT) Symposium: Genetic Engineering of T Cells

16 May 2016
10:15 AM – 12:15 PM
Room 618-620

American Society of Gene & Cell Therapy (ASGCT) Symposium: Genetic Engineering of T Cells

Chairs:
Michel Sadelain, Memorial Sloan Kettering Cancer Center
Stanley Riddell, Fred Hutchinson Cancer Research Center

Speakers:
Michel Sadelain, Memorial Sloan Kettering Cancer Center, Genetic engineering of chimeric antigen receptors
Jo Brewer, Adaptimmune LLC, T cell receptors
Stanley Riddell, Fred Hutchinson Cancer Research Center, What is the best T cell subset?
Ann M. Leen, Baylor College of Medicine, Genetically modified virus-specific cells